Ingvild Sørum Leikfoss

Ingvild Sørum Leikfoss has a diverse work experience in the field of research and scientific studies. From 2008 to 2010, they worked as a Master of Science at the University of Oslo, specializing in Molecular Biology. During this period, they also worked at the Center of Immune Regulation at Oslo University Hospital.

From 2010 to 2015, Ingvild served as a PhD student, focusing on molecular, immunological, and genetic studies in T cells. Ingvild actively participated in various projects, including sample collection for the Biobank, writing grant applications, and co-supervising master students.

In 2015, Ingvild transitioned to the role of Forskningskoordinator (Research Coordinator) at Universitetet i Oslo. Ingvild held this position for four years until December 2019, where they were involved in coordinating research activities.

In 2019, they joined Oslo University Hospital as a Researcher. Ingvild continued their research work until January 2020.

Currently, Ingvild Sørum Leikfoss is employed as a Scientist at Nykode Therapeutics, starting in January 2020. Additional information about their roles and responsibilities in this position is not provided.

Ingvild Sørum Leikfoss has an extensive education history in the field of molecular biology and immunology. Ingvild began their studies at the University of Oslo (UiO) in 2005, where they obtained their Bachelor's Degree in Molecular Biology in 2010. Ingvild then pursued a Master's Degree in Immunology from 2008 to 2010, also at the University of Oslo. Ingvild continued their education at UiO and completed their Doctor of Philosophy (Ph.D.) in Molecular Immunology from 2010 to 2015. Ingvild'sdedication to these programs highlights their expertise in the field and their commitment to advancing their knowledge in molecular immunology.